Search for other papers by Isabel M Abreu in
Google Scholar
PubMed
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar S. João, Alameda Professor Hernâni Monteiro, Porto, Portugal
Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
Search for other papers by Eva Lau in
Google Scholar
PubMed
Search for other papers by Bernardo de Sousa Pinto in
Google Scholar
PubMed
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar S. João, Alameda Professor Hernâni Monteiro, Porto, Portugal
Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
Search for other papers by Davide Carvalho in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism (SCH) is diagnosed biochemically when both serum-free thyroxine (FT4) and free triiodothyronine (FT3) are within the normal range, whereas the serum thyroid-stimulating hormone (TSH) is elevated ( 1
Search for other papers by Akinori Sairaku in
Google Scholar
PubMed
Search for other papers by Yukiko Nakano in
Google Scholar
PubMed
Search for other papers by Yuko Uchimura in
Google Scholar
PubMed
Search for other papers by Takehito Tokuyama in
Google Scholar
PubMed
Search for other papers by Hiroshi Kawazoe in
Google Scholar
PubMed
Search for other papers by Yoshikazu Watanabe in
Google Scholar
PubMed
Search for other papers by Hiroya Matsumura in
Google Scholar
PubMed
Search for other papers by Yasuki Kihara in
Google Scholar
PubMed
subclinical hypothyroidism ( 5 , 6 ), defined as a mild thyroid underactive condition in which the serum thyroid-stimulating hormone (TSH) concentration is raised while the serum thyroid hormone concentrations are normal ( 5 ). On the other hand, recent large
Search for other papers by L E Zijlstra in
Google Scholar
PubMed
Search for other papers by D M van Velzen in
Google Scholar
PubMed
Search for other papers by S Simsek in
Google Scholar
PubMed
Search for other papers by S P Mooijaart in
Google Scholar
PubMed
Department of Internal Medicine, HagaHospital, The Hague, The Netherlands
Search for other papers by M van Buren in
Google Scholar
PubMed
Search for other papers by D J Stott in
Google Scholar
PubMed
Search for other papers by I Ford in
Google Scholar
PubMed
Search for other papers by J W Jukema in
Google Scholar
PubMed
Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by S Trompet in
Google Scholar
PubMed
Introduction Subclinical hyperthyroidism has been linked to atrial fibrillation and coronary artery calcification, whereas subclinical hypothyroidism has been associated with hypercholesterolemia and atherosclerosis ( 1 , 2 ). Despite these
Search for other papers by Aasem Saif in
Google Scholar
PubMed
Search for other papers by Shrook Mousa in
Google Scholar
PubMed
Search for other papers by Maha Assem in
Google Scholar
PubMed
Search for other papers by Nashwa Tharwat in
Google Scholar
PubMed
Vascular Laboratory, Cairo University, Cairo, Egypt
Search for other papers by Alaa Abdelhamid in
Google Scholar
PubMed
such as dyslipidemia, hypercoagulable state, increased arterial stiffness, obesity and endothelial dysfunction ( 1 , 2 , 3 , 4 ). Current controversy centers on whether subclinical hypothyroidism (SCH) is associated with atherosclerosis. Some studies
Department of Clinical Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, China
Search for other papers by Ningning Gong in
Google Scholar
PubMed
Search for other papers by Cuixia Gao in
Google Scholar
PubMed
Search for other papers by Xuedi Chen in
Google Scholar
PubMed
Search for other papers by Yu Wang in
Google Scholar
PubMed
Search for other papers by Limin Tian in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism (sHT) is defined by increased thyroid-stimulating hormone (TSH) with normal thyroid hormone concentrations. The prevalence of sHT is 4–20% in adults ( 1 ). Recently, a relationship between sHT and
Department of Endocrinology and Metabolism, People's Hospital of Liaoning Province, Shenyang, People’s Republic of China
Search for other papers by Ling Shan in
Google Scholar
PubMed
Search for other papers by Yingying Zhou in
Google Scholar
PubMed
Search for other papers by Shiqiao Peng in
Google Scholar
PubMed
Department of Laboratory Medical, The First Hospital of China Medical University, Shenyang, People’s Republic of China
Search for other papers by Xinyi Wang in
Google Scholar
PubMed
Search for other papers by Zhongyan Shan in
Google Scholar
PubMed
Search for other papers by Weiping Teng in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism (SCH), characterized by elevated levels of thyroid-stimulating hormone (TSH) with total thyroxine (TT4) within the normal reference range, is the most common type of thyroid disorder in pregnancy ( 1
Search for other papers by Jeonghoon Ha in
Google Scholar
PubMed
Search for other papers by Jeongmin Lee in
Google Scholar
PubMed
Search for other papers by Kwanhoon Jo in
Google Scholar
PubMed
Search for other papers by Dong-Jun Lim in
Google Scholar
PubMed
Search for other papers by Moo Il Kang in
Google Scholar
PubMed
Search for other papers by Bong Yun Cha in
Google Scholar
PubMed
Search for other papers by Min-Hee Kim in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism (SCH) is defined as a mildly elevated serum thyroid-stimulating hormone (TSH) level with a serum free thyroxine (FT4) level within the normal range ( 1 ). While treatment of SCH is not mandatory in most
Search for other papers by Ursula M M Costa in
Google Scholar
PubMed
Search for other papers by Carla R P Oliveira in
Google Scholar
PubMed
Search for other papers by Roberto Salvatori in
Google Scholar
PubMed
Search for other papers by José A S Barreto-Filho in
Google Scholar
PubMed
Search for other papers by Viviane C Campos in
Google Scholar
PubMed
Search for other papers by Francielle T Oliveira in
Google Scholar
PubMed
Search for other papers by Ivina E S Rocha in
Google Scholar
PubMed
Search for other papers by Joselina L M Oliveira in
Google Scholar
PubMed
Search for other papers by Wersley A Silva in
Google Scholar
PubMed
Search for other papers by Manuel H Aguiar-Oliveira in
Google Scholar
PubMed
non-affected siblings (18) . Because coronary disease presents with a long latency period, it is important to know if subclinical atherosclerosis exists in these IGHD subjects. To answer this, it is necessary to assess asymptomatic individuals (19
Search for other papers by Sweta Budyal in
Google Scholar
PubMed
Search for other papers by Swati Sachin Jadhav in
Google Scholar
PubMed
Search for other papers by Rajeev Kasaliwal in
Google Scholar
PubMed
Search for other papers by Hiren Patt in
Google Scholar
PubMed
Search for other papers by Shruti Khare in
Google Scholar
PubMed
Search for other papers by Vyankatesh Shivane in
Google Scholar
PubMed
Search for other papers by Anurag R Lila in
Google Scholar
PubMed
Search for other papers by Tushar Bandgar in
Google Scholar
PubMed
Search for other papers by Nalini S Shah in
Google Scholar
PubMed
Introduction Subclinical Cushing's syndrome (SCS) is defined as autonomous cortisol secretion in patients without typical signs and symptoms of hypercortisolism, as in the classic Cushing's syndrome (CS) (1) . Screening for a rare disorder like SCS
Search for other papers by Nella Augusta Greggio in
Google Scholar
PubMed
Search for other papers by Elisa Rossi in
Google Scholar
PubMed
Search for other papers by Silvia Calabria in
Google Scholar
PubMed
Search for other papers by Alice Meneghin in
Google Scholar
PubMed
Search for other papers by Joaquin Gutierrez de Rubalcava in
Google Scholar
PubMed
Search for other papers by Carlo Piccinni in
Google Scholar
PubMed
Search for other papers by Antonella Pedrini in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism (SH) is a biochemical condition defined as serum thyroid-stimulating hormone (TSH) exceeding the limit of its reference range by age, while the concentration of serum free thyroxin (FT4) remains within